Susquehanna International Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-156,194
| Closed | -$6M | – | 13421 |
|
|
2023
Q2 | $6M | Buy |
156,194
+77,479
| +98% | +$1.99M | ﹤0.01% | 3235 |
|
|
2023
Q1 | $1.82M | Buy |
78,715
+51,432
| +189% | +$1.23M | ﹤0.01% | 5341 |
|
|
2022
Q4 | $715K | Sell |
27,283
-26,287
| -49% | -$582K | ﹤0.01% | 6970 |
|
|
2022
Q3 | $1.05M | Buy |
+53,570
| New | +$1.07M | ﹤0.01% | 6511 |
|
|
2022
Q2 | – | Sell |
-26,435
| Closed | -$415K | – | 14346 |
|
|
2022
Q1 | $432K | Sell |
26,435
-11,352
| -30% | -$154K | ﹤0.01% | 9354 |
|
|
2021
Q4 | $616K | Buy |
37,787
+10,892
| +40% | +$155K | ﹤0.01% | 8597 |
|
|
2021
Q3 | $343K | Buy |
26,895
+14,237
| +112% | +$187K | ﹤0.01% | 10289 |
|
|
2021
Q2 | $179K | Sell |
12,658
-13,409
| -51% | -$214K | ﹤0.01% | 11705 |
|
|
2021
Q1 | $405K | Sell |
26,067
-2,401
| -8% | -$39.2K | ﹤0.01% | 9960 |
|
|
2020
Q4 | $452K | Buy |
28,468
+25,593
| +890% | +$386K | ﹤0.01% | 8507 |
|
|
2020
Q3 | $35K | Buy |
+2,875
| New | +$38.5K | ﹤0.01% | 10298 |
|
|
2020
Q2 | – | Sell |
-3,806
| Closed | -$52.5K | – | 11186 |
|
|
2020
Q1 | $52K | Sell |
3,806
-8,974
| -70% | -$106K | ﹤0.01% | 9676 |
|
|
2019
Q4 | $76K | Buy |
12,780
+6,381
| +100% | +$34.7K | ﹤0.01% | 9235 |
|
|
2019
Q3 | $34K | Sell |
6,399
-2,983
| -32% | -$19.8K | ﹤0.01% | 9873 |
|
|
2019
Q2 | $72K | Buy |
+9,382
| New | +$143K | ﹤0.01% | 9742 |
|
|
2017
Q1 | – | Sell |
-9,916
| Closed | -$560K | – | 10249 |
|
|
2016
Q4 | $565K | Buy |
+9,916
| New | +$600K | ﹤0.01% | 6729 |
|
|
2016
Q3 | – | Sell |
-6,935
| Closed | -$490K | – | 9222 |
|
|
2016
Q2 | $392K | Buy |
+6,935
| New | +$421K | ﹤0.01% | 6529 |
|
|
2016
Q1 | – | Sell |
-1,746
| Closed | -$141K | – | 9853 |
|
|
2015
Q4 | $246K | Sell |
1,746
-1,141
| -40% | -$155K | ﹤0.01% | 8072 |
|
|
2015
Q3 | $280K | Buy |
2,887
+1,249
| +76% | +$149K | ﹤0.01% | 8161 |
|
|
2015
Q2 | $248K | Buy |
+1,638
| New | +$270K | ﹤0.01% | 8899 |
|
Susquehanna International Group's KDNY Position: Q3 2023 in Review
Susquehanna International Group sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 156,194 shares — an estimated $6M sold.
Susquehanna International Group first reported a position in KDNY in Q2 2015 and held it in 20 quarters. The position peaked at $6M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Susquehanna International Group reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 156,194 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $6M.
- Susquehanna International Group first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 20 quarters.
- Susquehanna International Group's Chinook Therapeutics, Inc. Common Stock position peaked at $6M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.